Bernstein’s latest research cuts several of America’s biggest packaged food names after a wave of headwinds.

Rising oil costs and the rapid adoption of GLP‑1 drugs threaten profit margins for firms that rely on stable commodity prices and steady consumer spending.

The analyst’s stance signals a shift in risk appetite for investors targeting the sector, as cost pressures and health‑driven dietary changes converge.

Market watchers will watch earnings releases closely; a tightening supply chain could squeeze margins and alter valuation multiples for the remaining players.